Natural Killer Cell Immunotherapy: From Bench to Bedside
The potential of natural killer (NK) cells to target numerous malignancies in vitro has been well documented; however, only limited success has been seen in the clinic. Although NK cells prove non-toxic and safe regardless of the cell numbers injected, there is often little persistence and expansion...
Main Authors: | Domogala, Anna, Madrigal, J. Alejandro, Saudemont, Aurore |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453475/ |
Similar Items
-
Transcription factors involved in the regulation of natural killer cell development and function: an update
by: Luevano, Martha, et al.
Published: (2012) -
Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty?
by: Souza-Fonseca-Guimaraes, Fernando, et al.
Published: (2013) -
From Bench to Bedside: Immunotherapy for Prostate Cancer
by: Tse, Brian Wan-Chi, et al.
Published: (2014) -
Frozen Cord Blood Hematopoietic Stem Cells Differentiate into Higher Numbers of Functional Natural Killer Cells In Vitro than Mobilized Hematopoietic Stem Cells or Freshly Isolated Cord Blood Hematopoietic Stem Cells
by: Luevano, Martha, et al.
Published: (2014) -
Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside
by: Ahmed, Md. Selim, et al.
Published: (2016)